Study on circulating tumor DNA shows clear benefits

After surgery for colon cancer, many patients face the question of whether follow-up chemotherapy is necessary to prevent a possible relapse. The decision is particularly difficult in so-called Stage II, the intermediate-risk ...

Muscle loss in liver disease varies by underlying cause

Different types of liver disease are leading to distinct signatures of muscle loss, according to a new study that could help pave the way for more personalized treatments for sarcopenia in people with end-stage liver disease. ...

page 9 from 40